Targeting Elongation Factor-2 Kinase to Reinforce ...
Melanoma, one of the most aggressive and fatal neoplasms, is responsible for over 80% of skin cancer-related deaths. As melanoma mostly expresses tumor-specific neo-antigen...
Melanoma, one of the most aggressive and fatal neoplasms, is responsible for over 80% of skin cancer-related deaths. As melanoma mostly expresses tumor-specific neo-antigen...
Study Goals: Reveal how a molecule called neuritin supports a population of immune cells that actively interferes with the killing of melanomas; determine if ther...
Description: Melanoma of the uveal tract (a region of the eye) is the most common ocular malignancy in adults and accounts for 5% of all melanomas. According to N...
Description: Mutations in a small number of genes are found in a large fraction of human melanomas. For instance, so-called “driver” mutations in the “famous” melan...
Description: Treatment of advanced melanoma with immunotherapy agents shows striking responses in some patients, however overall responses are low. In addition, a significa...
Established Investigator Award – Ashani Weeraratna, PhD
Established Investigator Award – Rutao Cui
Established Investigator Award – Linda Bradley
Established Investigator Award – Dr. Ze’ev Ronai
Established Investigator Award – Dr. Jacqueline Lees
Established Investigator Award – Dr. Eduardo Davila
CURE OM funded Established Investigator – CURE OM – Dr. William Tansey
Nov 22, 2025 PT